Cholesterol and heart attack severity study
Part of Heart & circulation clinical trials.
This study looks at whether two blood tests, one for a type of cholesterol and one for a ratio of certain cells, can predict how serious a heart attack is and how blocked the arteries are. The results might help doctors personalize treatment for people with acute coronary syndrome.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are currently having a heart attack or unstable chest pain (acute coronary syndrome)
- You are scheduled for a procedure to open blocked heart arteries (primary PCI)
- You have not taken cholesterol-lowering medication (statins) before
- Your kidneys are functioning well (no severe kidney disease)
- You can understand and sign a consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study examines blood samples from people with different types of coronary artery disease to understand the condition better. It may help doctors learn how to treat heart problems in the future.
This study is checking if a simple blood test (hs-CRP to albumin ratio) can help predict outcomes in people who have had a heart attack or unstable angina but are not getting an immediate balloon/stent procedure. It aims to use inflammation markers to guide better care.
This study tests whether giving a new cholesterol-lowering drug, inclisiran, early during a hospital stay after a heart attack can help lower bad cholesterol (LDL) more effectively than usual care. It may reduce the risk of future heart problems.
This study looks at whether certain blood markers (related to inflammation and heart damage) can help tell how well your heart is working after a heart attack. By joining, you could help doctors better predict heart function problems and improve care for future patients.
This study tests an extra medication (inclisiran) added to your usual cholesterol-lowering treatment, compared to usual treatment alone, to see if it further lowers 'bad' cholesterol after a recent heart attack.
This trial tests a new way to check heart risk and start treatment for cholesterol in people coming to the emergency room with chest pain or possible heart attack. It aims to see if early risk assessment and treatment can prevent future heart problems.
Hear when a new Acute Coronary Syndrome trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.